DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences—part 1: general aspects and paradigmatic discussion of depressive disorders

European Archives of Psychiatry and Clinical Neuroscience

Volumn 265, Issue 1, 2015, Pages 5-18

  Möller, Hans Jürgen ^a   Bandelow, Borwin ^b   Bauer, Michael ^c   Hampel, Harald ^d   Herpertz, Sabine C ^e   Soyka, Michael ^a,f   Barnikol, Utako B ^g   Lista, Simone ^d   Severus, Emanuel ^c   Maier, Wolfgang ^h  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f Private Hospital Meiringen   (Switzerland)

^g UNIVERSITY OF COLOGNE   (Germany)

^h UNIVERSITY OF BONN   (Germany)

Author keywords

Categorical classification; Depressive disorders; Diagnosis; Dimensional classification; DSM 5; Standardised assessments

Indexed keywords

CLASSIFICATION; DEPRESSIVE DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMAN; SYMPTOM ASSESSMENT;

DEPRESSIVE DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; SYMPTOM ASSESSMENT;

EID: 84939893601     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-014-0520-x     Document Type: Article

References (89)

1. Akiskal HS, Benazzi F, Perugi G, Rihmer Z (2005) Agitated “unipolar” depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy. J Affect Disord 85:245–258
2. American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Publishing, Arlington
3. Andrews G, Brugha T, Thase ME, Duffy FF, Rucci P, Slade T (2007) Dimensionality and the category of major depressive episode. Int J Methods Psychiatr Res 16(Suppl 1):S41–S51
4. Angst J, Azorin JM, Bowden CL, Perugi G, Vieta E, Gamma A, Young AH (2011) Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study. Arch Gen Psychiatry 68:791–798
5. Angst J, Cui L, Swendsen J, Rothen S, Cravchik A, Kessler RC, Merikangas KR (2010) Major depressive disorder with subthreshold bipolarity in the national comorbidity survey replication. Am J Psychiatry 167:1194–1201
6. Angst J, Gamma A, Benazzi F, Ajdacic V, Eich D, Rossler W (2003) Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. J Affect Disord 73:133–146
7. Axelson D, Findling RL, Fristad MA, Kowatch RA, Youngstrom EA, Horwitz SM, Arnold LE, Frazier TW, Ryan N, Demeter C, Gill MK, Hauser-Harrington JC, Depew J, Kennedy SM, Gron BA et al (2012) Examining the proposed disruptive mood dysregulation disorder diagnosis in children in the longitudinal assessment of manic symptoms study. J Clin Psychiatry 73:1342–1350
8. Baldessarini RJ, Faedda GL, Offidani E, Vazquez GH, Marangoni C, Serra G, Tondo L (2013) Antidepressant-associated mood-switching and transition from unipolar major depression to bipolar disorder: a review. J Affect Disord 148:129–135
9. Berk M (2013) The DSM-5: hyperbole, hope or hypothesis? BMC Med 11:128
10. Blennow K, Hampel H, Weiner M, Zetterberg H (2010) Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 6:131–144
11. Brown TA, Di Nardo PA, Lehman CL, Campbell LA (2001) Reliability of DSM-IV anxiety and mood disorders: implications for the classification of emotional disorders. J Abnorm Psychol 110:49–58
12. Carroll BJ (2013) Biomarkers in DSM-5: lost in translation. Aust N Z J Psychiatry 47:676–678
13. Carroll BJ (2012) Bringing back melancholia. Bipolar Disord 14:1–5
14. Clarke DE, Narrow WE, Regier DA, Kuramoto SJ, Kupfer DJ, Kuhl EA, Greiner L, Kraemer HC (2013) DSM-5 field trials in the United States and Canada, part I: study design, sampling strategy, implementation, and analytic approaches. Am J Psychiatry 170:43–58
15. Copeland WE, Angold A, Costello EJ, Egger H (2013) Prevalence, comorbidity, and correlates of DSM-5 proposed disruptive mood dysregulation disorder. Am J Psychiatry 170:173–179
16. Copeland WE, Shanahan L, Egger H, Angold A, Costello EJ (2014) Adult diagnostic and functional outcomes of DSM-5 disruptive mood dysregulation disorder. Am J Psychiatry 171:668–674
17. Coryell W, Fiedorowicz JG, Solomon D, Leon AC, Rice JP, Keller MB (2012) Effects of anxiety on the long-term course of depressive disorders. Br J Psychiatry 200:210–215
18. Cuthbert BN (2014) The RDoC framework: facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology. World Psychiatry 13:28–35
19. Cuthbert BN, Insel TR (2013) Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med 11:126
20. Dimsdale JE (2013) Somatic symptom disorders: a new approach in DSM-5. Die Psychiatrie 10:30–32
21. Dunner DL (2003) Clinical consequences of under-recognized bipolar spectrum disorder. Bipolar Disord 5:456–463
22. Egli S, Riedel M, Moller HJ, Strauss A, Lage D (2009) Creating a map of psychiatric patients based on psychopathological symptom profiles. Eur Arch Psychiatry Clin Neurosci 259:164–171
23. Epperson CN, Steiner M, Hartlage SA, Eriksson E, Schmidt PJ, Jones I, Yonkers KA (2012) Premenstrual dysphoric disorder: evidence for a new category for DSM-5. Am J Psychiatry 169:465–475
24. Ewers M, Sperling RA, Klunk WE, Weiner MW, Hampel H (2011) Neuroimaging markers for the prediction and early diagnosis of Alzheimer’s disease dementia. Trends Neurosci 34:430–442
25. Fawcett J (2010) An overview of mood disorders in the DSM-5. Curr Psychiatry Rep 12:531–538
26. First MB (2014) Preserving the clinician–researcher interface in the age of RDoC: the continuing need for DSM-5/ICD-11 characterization of study populations. World Psychiatry 13:53–54
27. Flint J, Kendler KS (2014) The genetics of major depression. Neuron 81:484–503
28. Goldberg D (2008) Towards DSM-V: the relationship between generalized anxiety disorder and major depressive episode. Psychol Med 38:1671–1675
29. Goldberg DP (2010) Diagnostic issues in depression and generalized anxiety disorder. Refining the research agenda for DSM-V. American Psychiatric Association, Arlington
30. Goldberg DP, Wittchen HU, Beesdo-Baum K, Zimmermann P, Pfister H (2013) Anxious and non-anxious forms of major depression: familial, personality and symptom characteristics. Psychol Med 1–12
31. Hampel H, Frank R, Broich K, Teipel SJ, Katz RG, Hardy J, Herholz K, Bokde AL, Jessen F, Hoessler YC, Sanhai WR, Zetterberg H, Woodcock J, Blennow K (2010) Biomarkers for Alzheimer’s disease: academic, industry and regulatory perspectives. Nat Rev Drug Discov 9:560–574
32. Hartlage SA, Breaux CA, Yonkers KA (2014) Addressing concerns about the inclusion of premenstrual dysphoric disorder in DSM-5. J Clin Psychiatry 75:70–76
33. Hollander E (2011) Obsessive–compulsive spectrum disorders: refining the research agenda for DSM-V. American Psychiatric Association, Arlington
34. Hyman SE (2008) Can neuroscience be integrated into the DSM-V? Nat Rev Neurosci 8:725–732
35. Insel T (2013) Director’s Blog: Transforming Diagnosis. National Institute of Mental Health. http://www.nimh.nih.gov/about/director/2013/transforming-diagnosis.shtml. Accessed 13 Dec 2013
36. Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, Sanislow C, Wang P (2010) Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry 167:748–751
37. Kendler K (2008) Book review: the loss of sadness: how psychiatry transformed normal sorrow into depressive disorder, by Horwitz AB, Wakefield JC. Psychol Med 39:1935–1941
38. Kendler KS (2009) An historical framework for psychiatric nosology. Psychol Med 39:1935–1941
39. Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ (1992) Major depression and generalized anxiety disorder. Same genes, (partly) different environments? Arch Gen Psychiatry 49:716–722
40. Kleinman A (2012) Culture, bereavement, and psychiatry. Lancet 379:608–609
41. Koutsouleris N, Borgwardt S, Meisenzahl EM, Bottlender R, Moller HJ, Riecher-Rossler A (2012) Disease prediction in the at-risk mental state for psychosis using neuroanatomical biomarkers: results from the FePsy study. Schizophr Bull 38:1234–1246
42. Koutsouleris N, Davatzikos C, Borgwardt S, Gaser C, Bottlender R, Frodl T, Falkai P, Riecher-Rossler A, Moller HJ, Reiser M, Pantelis C, Meisenzahl E (2013) Accelerated brain aging in schizophrenia and beyond: a neuroanatomical marker of psychiatric disorders. Schizophr Bull. doi:10.1093/schbul/sbt142
43. Kupfer DJ, Frank E, Phillips ML (2012) Major depressive disorder: new clinical, neurobiological, and treatment perspectives. Lancet 379:1045–1055
44. Kupfer DJ, Regier DA (2011) Neuroscience, clinical evidence, and the future of psychiatric classification in DSM-5. Am J Psychiatry 168:672–674
45. Lage D, Egli S, Riedel M, Moller HJ (2012) Exploring the structure of psychopathological symptoms: a re-analysis of AMDP data by robust nonmetric multidimensional scaling. Eur Arch Psychiatry Clin Neurosci 262:227–238
46. Lage D, Egli S, Riedel M, Strauss A, Moller HJ (2011) Combining the categorical and the dimensional perspective in a diagnostic map of psychotic disorders. Eur Arch Psychiatry Clin Neurosci 261:3–10
47. Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, Mowry BJ, Thapar A, Goddard ME, Witte JS, Absher D, Agartz I, Akil H, Amin F, Andreassen OA et al (2013) Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet 45:984–994
48. Leibenluft E (2011) Severe mood dysregulation, irritability, and the diagnostic boundaries of bipolar disorder in youths. Am J Psychiatry 168:129–142
49. Maier W, Zobel A, Wagner M (2006) Schizophrenia and bipolar disorder: differences and overlaps. Curr Opin Psychiatry 19:165–170
50. Maj M (2012) Bereavement-related depression in the DSM-5 and ICD-11. World Psychiatry 11:1–2
51. Maj M (2013) “Clinical judgment” and the DSM-5 diagnosis of major depression. World Psychiatry 12:89–91
52. Maj M (2013) Mood disorders in ICD-11 and DSM-5. Die Psychiatrie 10:24–29
53. Maj M, Pirozzi R, Magliano L, Fiorillo A, Bartoli L (2007) Phenomenology and prognostic significance of delusions in major depressive disorder: a 10-year prospective follow-up study. J Clin Psychiatry 68:1411–1417
54. Malhi GS (2013) Diagnosis of bipolar disorder: who is in a mixed state? Lancet 381:1599–1600
55. Moller HJ (in press) The consequences of DSM-5 for psychiatric diagnosis and psychopharmacotherapy. Int J Psychiatry Clin Pract
56. Moller HJ (2009) Development of DSM-V and ICD-11: tendencies and potential of new classifications in psychiatry at the current state of knowledge. Psychiatry Clin Neurosci 63:595–612
57. Moller HJ (in press) Dichotomy versus spectrum concept in approaching psychotic disorders: are we ready to make the final decision?. In: Soldatos C, Ruiz P, Dikeos D, Riba M (eds) Proceedings of the WPA thematic conference on intersectional collaboration 4th European congress of INA and the 1st interdisciplinary congress of HSAPRS, Athens, Greece, Nov 29 to Dec 2, 2012. Medimond s.r.l., Pianoro, Italy
58. Moller HJ (2008) The forthcoming revision of the diagnostic and classificatory system: perspectives based on the European psychiatric tradition. Eur Arch Psychiatry Clin Neurosci 258(Suppl 5):7–17
59. Moller HJ (2008) Is there a need for a new psychiatric classification at the current state of knowledge? World J Biol Psychiatry 9:82–85
60. Moller HJ (2005) Problems associated with the classification and diagnosis of psychiatric disorders. World J Biol Psychiatry 6:45–56
61. Moller HJ (2009) Standardised rating scales in psychiatry: methodological basis, their possibilities and limitations and descriptions of important rating scales. World J Biol Psychiatry 10:6–26
62. Moller HJ (2008) Systematic of psychiatric disorders between categorical and dimensional approaches: Kraepelin’s dichotomy and beyond. Eur Arch Psychiatry Clin Neurosci 258(Suppl 2):48–73
63. Moller HJ, Jager M, Riedel M, Obermeier M, Strauss A, Bottlender R (2011) The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: assessing courses, types and time stability of diagnostic classification. Eur Psychiatry 26:231–243
64. Narrow WE, Clarke DE, Kuramoto SJ, Kraemer HC, Kupfer DJ, Greiner L, Regier DA (2013) DSM-5 field trials in the United States and Canada, part III: development and reliability testing of a cross-cutting symptom assessment for DSM-5. Am J Psychiatry 170:71–82
65. Papakostas GI, Shelton RC, Kinrys G, Henry ME, Bakow BR, Lipkin SH, Pi B, Thurmond L, Bilello JA (2013) Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study. Mol Psychiatry 18:332–339
66. Patkar A, Gilmer W, Pae CU, Vohringer PA, Ziffra M, Pirok E, Mulligan M, Filkowski MM, Whitham EA, Holtzman NS, Thommi SB, Logvinenko T, Loebel A, Masand P, Ghaemi SN (2012) A 6 week randomized double-blind placebo-controlled trial of ziprasidone for the acute depressive mixed state. PLoS One 7:e34757
67. Perlis RH, Cusin C, Fava M (2012) Proposed DSM-5 mixed features are associated with greater likelihood of remission in out-patients with major depressive disorder. Psychol Med 1–7
68. Phillips KA, Stein DJ, Rauch SL, Hollander E, Fallon BA, Barsky A, Fineberg N, Mataix-Cols D, Ferrao YA, Saxena S, Wilhelm S, Kelly MM, Clark LA, Pinto A, Bienvenu OJ et al (2010) Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V? Depress Anxiety 27:528–555
69. Phillips ML, Kupfer DJ (2013) Bipolar disorder diagnosis: challenges and future directions. Lancet 381:1663–1671
70. Regier DA, Kuhl EA, Kupfer DJ (2013) The DSM-5: classification and criteria changes. World Psychiatry 12:92–98
71. Regier DA, Narrow WE, Clarke DE, Kraemer HC, Kuramoto SJ, Kuhl EA, Kupfer DJ (2013) DSM-5 field trials in the United States and Canada, part II: test–retest reliability of selected categorical diagnoses. Am J Psychiatry 170:59–70
72. Seemuller F, Riedel M, Obermeier M, Schennach-Wolff R, Spellmann I, Meyer S, Bauer M, Adli M, Kronmuller K, Ising M, Brieger P, Laux G, Bender W, Heuser I, Zeiler J et al (2012) The validity of self-rated psychotic symptoms in depressed in patients. Eur Psychiatry 27:547–552
73. Sparks GM, Axelson DA, Yu H, Ha W, Ballester J, Diler RS, Goldstein B, Goldstein T, Hickey MB, Ladouceur CD, Monk K, Sakolsky D, Birmaher B (2014) Disruptive mood dysregulation disorder and chronic irritability in youth at familial risk for bipolar disorder. J Am Acad Child Adolesc Psychiatry 53:408–416
74. Stahl SM (2013) The last diagnostic and statistical manual (DSM): replacing our symptom-based diagnoses with a brain circuit-based classification of mental illnesses. CNS Spectr 18:65–68
75. Starcevic V, Portman ME (2013) The status quo as a good outcome: how the DSM-5 diagnostic criteria for generalized anxiety disorder remained unchanged from the DSM-IV criteria. Aust N Z J Psychiatry 47:995–997
76. Steinmeyer EM, Klosterkotter J, Moller HJ, Sass H, Herpertz S, Czernik A, Marcea JT, Matakas F, Mehne J, Bottlander H, Hesse W, Steinbring I, Pukrop R (2002) Personality and personality disorders I. Universality and sensitivity of dimensional personality models as diagnostic systems for personality disorders. Fortschr Neurol Psychiatr 70:630–640
77. Steinmeyer EM, Klosterkotter J, Moller HJ, Sass H, Herpertz S, Czernik A, Marcea JT, Matakas F, Mehne J, Bottlander H, Hesse W, Steinbring I, Pukrop R (2002) Personality and personality disorders II. The Specificity of the DAPP-model as a diagnostic system for personality disorders. Fortschr Neurol Psychiatr 70:641–646
78. Stringaris A, Cohen P, Pine DS, Leibenluft E (2009) Adult outcomes of youth irritability: a 20-year prospective community-based study. Am J Psychiatry 166:1048–1054
79. Sunderland T, Association American Psychiatric (2007) Diagnostic issues in dementia: advancing the research agenda for DSM-V. American Psychiatric Association, Arlington
80. Tamminga CA (2010) Deconstructing psychosis: refining the research agenda for DSM-V. American Psychiatric Association, Arlington
81. Tohen M, Strakowski SM, Zarate C Jr, Hennen J, Stoll AL, Suppes T, Faedda GL, Cohen BM, Gebre-Medhin P, Baldessarini RJ (2000) The McLean-Harvard first-episode project: 6-month symptomatic and functional outcome in affective and nonaffective psychosis. Biol Psychiatry 48:467–476
82. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M (2006) Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 163:28–40
83. Uher R, Farmer A, Maier W, Rietschel M, Hauser J, Marusic A, Mors O, Elkin A, Williamson RJ, Schmael C, Henigsberg N, Perez J, Mendlewicz J, Janzing JG, Zobel A et al (2008) Measuring depression: comparison and integration of three scales in the GENDEP study. Psychol Med 38:289–300
84. Uher R, Payne JL, Pavlova B, Perlis RH (2013) Major depressive disorder in DSM-5: implications for clinical practice and research of changes from DSM-IV. Depress Anxiety
85. van Os J, Delespaul P, Wigman J, Myin-Germeys I, Wichers M (2013) Beyond DSM and ICD: introducing “precision diagnosis” for psychiatry using momentary assessment technology. World Psychiatry 12:113–117
86. Vieta E, Valenti M (2013) Mixed states in DSM-5: implications for clinical care, education, and research. J Affect Disord 148:28–36
87. World Health Organization (2010) International Classification of Diseases, 10th Revision (ICD-10). In: World Health Organization, Geneva
88. Zielasek J, Gaebel W (2008) Modern modularity and the road towards a modular psychiatry. Eur Arch Psychiatry Clin Neurosci 258(Suppl 5):60–65
89. Zimmermann P, Bruckl T, Nocon A, Pfister H, Lieb R, Wittchen HU, Holsboer F, Angst J (2009) Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity. Arch Gen Psychiatry 66:1341–1352